Literature DB >> 12357152

Early effects of acid-base management during hypothermia on cerebral infarct volume, edema, and cerebral blood flow in acute focal cerebral ischemia in rats.

Rainer Kollmar1, Thomas Frietsch, Dimitrios Georgiadis, Wolf-Rüdiger Schäbitz, Klaus F Waschke, Wolfgang Kuschinsky, Stefan Schwab.   

Abstract

BACKGROUND: Although the frequency for the use of moderate hypothermia in acute ischemic stroke is increasing, the optimal acid-base management during hypothermia remains unclear. This study investigates the effect of pH- and alpha-stat acid-base management on cerebral blood flow (CBF), infarct volume, and cerebral edema in a model of transient focal cerebral ischemia in rats.
METHODS: Twenty Sprague-Dawley rats were subjected to transient middle cerebral artery occlusion (MCAO) for 2 h during normothermic conditions followed by 5 h of reperfusion during hypothermia (33 degrees C). Animals were artificially ventilated with either alpha- (n = 10) or pH-stat management (n = 10). CBF was analyzed 7 h after induction of MCAO by iodo[(14)C]antipyrine autoradiography. Cerebral infarct volume and cerebral edema were measured by high-contrast silver infarct staining (SIS).
RESULTS: Compared with the alpha-stat regimen, pH-stat management reduced cerebral infarct volume (98.3 +/- 33.2 mm(3) vs. 53.6 +/- 21.6 mm(3); P > or = 0.05 mean +/- SD) and cerebral edema (10.6 +/- 4.0% vs. 3.1 +/- 2.4%; P > or = 0.05). Global CBF during pH-stat management exceeded that of alpha-stat animals (69.5 +/- 12.3 ml x 100 g(-1) x min(-1) vs. 54.7 +/- 13.3 ml x 100 g(-1) x min; P > or = 0.05). The regional CBF of the ischemic hemisphere was 62.1 +/- 11.2 ml x 100 g(-1) x min(-1) in the pH-stat group versus 48.2 +/- 7.2 ml x 100 g(-1) x min(-1) in the alpha-stat group ( P> or = 0.05).
CONCLUSIONS: In the very early reperfusion period (5 h), pH-stat management significantly decreases cerebral infarct volume and edema as compared with alpha-stat during moderate hypothermia, probably by increasing CBF.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12357152     DOI: 10.1097/00000542-200210000-00018

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  8 in total

Review 1.  Therapeutic hypothermia for acute ischemic stroke: ready to start large randomized trials?

Authors:  H Bart van der Worp; Malcolm R Macleod; Rainer Kollmar
Journal:  J Cereb Blood Flow Metab       Date:  2010-03-31       Impact factor: 6.200

Review 2.  Therapeutic temperature modulation in neurocritical care.

Authors:  Neeraj Badjatia
Journal:  Curr Neurol Neurosci Rep       Date:  2006-11       Impact factor: 5.081

Review 3.  [Therapeutic hypothermia and acid-base management].

Authors:  F Bach; F Mertzlufft
Journal:  Anaesthesist       Date:  2007-04       Impact factor: 1.041

4.  Alpha-stat versus pH-stat guided ventilation in patients with large ischemic stroke treated by hypothermia.

Authors:  Rainer Kollmar; Dimitrios Georgiadis; Stefan Schwab
Journal:  Neurocrit Care       Date:  2008-11-11       Impact factor: 3.210

Review 5.  [Neuroprotection in neurocritical care].

Authors:  Rainer Kollmar
Journal:  Med Klin Intensivmed Notfmed       Date:  2019-08-28       Impact factor: 0.840

6.  Hypocarbia and adverse outcome in neonatal hypoxic-ischemic encephalopathy.

Authors:  Athina Pappas; Seetha Shankaran; Abbot R Laptook; John C Langer; Rebecca Bara; Richard A Ehrenkranz; Ronald N Goldberg; Abhik Das; Rosemary D Higgins; Jon E Tyson; Michele C Walsh
Journal:  J Pediatr       Date:  2010-12-10       Impact factor: 4.406

7.  Treadmill Exercise during Pregnancy Decreased Vulnerability to Neonatal Hypoxia-Ischemia through Reducing Inflammation and Increasing Antiapoptotic Gene Expressions and Antioxidant Capacity in Rats.

Authors:  Elahe Gorgij; Hamed Fanaei; Parichehr Yaghmaei; Mohammad Reza Shahraki; Hadi Mirahmadi
Journal:  Stroke Res Treat       Date:  2021-04-14

Review 8.  Physiological Changes in Subjects Exposed to Accidental Hypothermia: An Update.

Authors:  Lars J Bjertnæs; Torvind O Næsheim; Eirik Reierth; Evgeny V Suborov; Mikhail Y Kirov; Konstantin M Lebedinskii; Torkjel Tveita
Journal:  Front Med (Lausanne)       Date:  2022-02-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.